Targeted testing for common molecule could improve cardiovascular risk prediction

Researchers at Keele University have said that more targeted use of testing for a common molecule could help to improve predictions of cardiovascular disease outcomes in patients at greatest risk.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup